Clinical TrialID 5537

Anticoagulation for Aortic Bioprosthesis (ANTIPRO)

NCT03807921

Aortic Valve Stenosis|Aortic Valve Disease|Aortic Valve Insufficiency|Aortic Valve Regurgitation

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
5537
Evidence Id
5537
Core Evidence Id
5537
Source Clinical Trial Id
5519
Herb2 Clinical Trial Id
HBCT005519
Nct Id
NCT03807921
Title
Anticoagulation for Aortic Bioprosthesis (ANTIPRO)
Status
Completed
Phase
Phase 4
Study Result
No
Study Condition
Aortic Valve Stenosis|Aortic Valve Disease|Aortic Valve Insufficiency|Aortic Valve Regurgitation
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Warfarin|DRUG: Aspirin
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Single
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
140
Outcome Measure
Transprosthetic aortic gradient, Change in Transprosthetic mean gradient, 3 months and 1 year|Change in New York Heart Association (NYHA) class, NYHA class, 1 year
Sponsor Collaborator
Instituto Nacional de Cirugia Cardiaca, Uruguay|Universidad de la Republica
Funded By
OTHER
Location
Centro Cardiovascular Universitario, Montevideo, Uruguay|Instituto Nacional de Cirugia Cardiaca, Montevideo, Uruguay
Other Id
ANTIPRO
Start Date
2019-01-01
Primary Completion Date
2019-12-30
Completion Date
2019-12-31
First Posted
2019-01-17
Results First Posted
Last Update Posted
2022-03-08
Study Document
Study Url
https://clinicaltrials.gov/study/NCT03807921
Title Cn
Title En
Anticoagulation for Aortic Bioprosthesis (ANTIPRO)
Bilingual Status
semi_complete